Related Experiment Video
Updated: Aug 31, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Heparin-Induced Thrombocytopenia After Cardiac Surgery-A Statewide Review of Health Care Utilization
Lekha V Yesantharao1, Eric W Etchill1, Joseph Canner1
1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Insights
Heparin-induced thrombocytopenia (HIT) after cardiac surgery significantly increases hospital costs and mortality. Early strategies to minimize HIT could improve patient outcomes and reduce healthcare expenses.
Area of Science:
- Cardiology
- Hematology
- Health Economics
Background:
- Heparin-induced thrombocytopenia (HIT) poses severe clinical and economic challenges after cardiac operations.
- The precise impacts of HIT on patient outcomes and resource utilization following cardiac surgery remain incompletely understood.
Purpose of the Study:
- To characterize the statewide incidence and outcomes of HIT in cardiac surgery patients.
- To assess the economic impact and resource consumption associated with postoperative HIT.
Main Methods:
- Retrospective analysis of cardiac surgery patients from the Maryland Health Services Cost Review Commission database (2012-2020).
- Comparison of health care costs, utilization, and outcomes between patients with and without postoperative HIT, utilizing propensity score matching.
Main Results:
- Postoperative HIT was diagnosed in 0.55% of 33,583 cardiac surgery patients.
- HIT patients experienced longer hospitalizations (21 vs. 7 days), higher mortality (13.6% vs. 2.3%), and greater hospital charges ($123,160 vs. $45,303), even after matching.
- Readmission rates and associated charges did not differ significantly between HIT and non-HIT groups.
Conclusions:
- HIT is associated with significantly worse outcomes and increased costs during initial hospital admissions for cardiac surgery patients.
- Implementing strategies to reduce HIT incidence may enhance patient outcomes and lower healthcare expenditures, aligning with value-based care objectives.
Background:
Despite its severe consequences, clinical and economic impacts of heparin-induced thrombocytopenia (HIT) after cardiac operations have not been well characterized. This study assessed statewide incidence, outcomes, and resource consumption associated with HIT after cardiac operations.
Methods:
This was a retrospective investigation of cardiac surgery patients using the Maryland Health Services Cost Review Commission's database from 2012 to 2020. Health care costs, utilization, and outcomes for those who experienced postoperative HIT were compared with propensity score-matched controls.
Results:
Of 33 583 cardiac surgery patients, 184 (0.55%) were diagnosed with postoperative HIT. Compared with non-HIT patients, HIT patients were significantly more likely to be in the oldest age group (>80 years; P < .001) and to have greater severity of illness at admission (P < .001). HIT was associated with a longer hospitalization (21 vs 7 days; P < .001), greater mortality (13.6% vs 2.3%; P < .001), and greater hospital charges ($123 160 vs $45 303; P < .001), even after propensity score matching. Readmission rates were not significantly different, however, and readmission hospital charges did not significantly differ between HIT and non-HIT patients.
Conclusions:
In addition to worse outcomes, HIT was associated with higher costs during index admissions but not during readmissions of cardiac surgery patients. Strategies to minimize HIT could yield better outcomes and reduced costs, particularly relevant for health care systems seeking improved value-based care while reducing unnecessary hospitalizations.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

